[CAS NO. 2482-00-0]  Agmatine sulfate

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [2482-00-0]

Catalog
HY-101238
Brand
MCE
CAS
2482-00-0

DESCRIPTION [2482-00-0]

Overview

MDLMFCD00013109
Molecular Weight228.27
Molecular FormulaC5H16N4O4S
SMILESNC(NCCCCN)=N.O=S(O)(O)=O

For research use only. We do not sell to patients.

Summary

Agmatine sulfate exerts modulatory action at multiple molecular targets, such as neurotransmitter systems, ion channels and nitric oxide synthesis. It is an endogenous agonist at imidazoline receptor and a NO synthase inhibitor.


IC50 & Target

Human Endogenous Metabolite


In Vitro

Agmatine binds to alpha 2-adrenergic and imidazoline receptors and stimulates release of catecholamines from adrenal chromaffin cells. Its biosynthetic enzyme, arginine decarboxylase, is present in brain. Agmatine, locally synthesized, is an endogenous agonist at imidazoline receptors, a noncatecholamine ligand at alpha 2-adrenergic receptors and may act as a neurotransmitter [1] . Agmatine is synthesized in the brain, stored in synaptic vesicles in regionally selective neurons, accumulated by uptake, released by depolarization, and inactivated by agmatinase. Agmatine inhibits nitric oxide synthase, and induces the release of some peptide hormones [2] . Agmatine, 4-(aminobutyl)guanidine, is produced by decarboxylation of L-arginine by the enzyme arginine decarboxylase. Agmatine is a competitive inhibitor of all NOS isoenzymes but not an NO precursor. K i values are approximately 660 µM (NOS I), 220 µM (NOS II) and 7.5 mM (NOS III) [3] . Agmatine stimulates nitrite production three-fold above basal nitrite formation by endothelial cells. Agmatine displaces [ 3 H]-idazoxan from endothelial cellmembranes and is found to induce transients in the cytosolic calcium of endothelial cells. The transients could be downregulated by repeated exposure to agmatine but are not affected by pretreatment with norepinephrine [4] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


In Vivo

Agmatine produces an antidepressant-like effect when assessed in the forced swimming test and in the tail suspension test in mice (dose range 0.01-50 mg/kg, i.p.), without accompanying changes in ambulation in an open-field [5] . In ischemic stroke, agmatine protects the blood-brain barrier, which can be monitored in vivo by quantification of permeability by using dynamic contrast-enhanced MR imaging [6] . Agmatine substantially augments the antidepressant-like effect of MK-801, reinforcing the notion that this compound modulates NMDA receptor activation [7] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

4°C, sealed storage, away from moisture

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)


Solvent & Solubility

In Vitro:

H 2 O : ≥ 100 mg/mL ( 438.08 mM )

DMSO : 1 mg/mL ( 4.38 mM ; ultrasonic and warming and heat to 80°C)

* "≥" means soluble, but saturation unknown.

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 4.3808 mL 21.9039 mL 43.8078 mL
5 mM 0.8762 mL 4.3808 mL 8.7616 mL
10 mM 0.4381 mL 2.1904 mL 4.3808 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: PBS

    Solubility: 25 mg/mL (109.52 mM); Clear solution; Need ultrasonic and warming

* All of the co-solvents are available by MCE.


Synonyms

Guanidine, N-(4-aminobutyl)-, sulfate (1:1)
Guanidine, (4-aminobutyl)-, sulfate (1:1)
Agmatine sulfate
NIH 11035
1-(4-Aminobutyl)guanidine sulfate